Healthcare Industry News: Solos Endoscopy
News Release - December 18, 2007
Solos Endoscopy, Inc. Realizes Steady Sales Increase in the 3rd Quarter of 2007BOSTON, MA--(Healthcare Sales & Marketing Network)--Dec 18, 2007 -- Solos Endoscopy, Inc. (Other OTC:SLSY.PK ) is pleased to announce that the Company has completed its third quarter financials and has realized a 16% increase in sales over the same period last year. Part of the growth was attributed to growing medical industry interest in Solos Endoscopy's breast endoscopy product line.
The Solos Breast Endoscopy system is ideal for performing Ductoscopy procedures, which allow physicians to examine the mammary ducts under direct visualization and consequently provides earlier detection than other procedures, including mammography. The Company will be posting information on the new endoscopy system on their website at www.solosendoscopy.com.
The Solos Breast Endoscopy System employs advanced microendoscopes and optical technology to give physicians sharp, clear images of the milk ducts, where the majority of breast cancers arise. The system is a versatile and customizable piece of medical equipment that can support multiple procedures including biopsies, lumpectomies, and other intraductal procedures. The Solos Breast Endoscopy System has the potential to help in the early diagnosis of more than 1 million cases of breast cancer discovered each year throughout the world.
"We are very pleased with the overwhelming response we have received regarding our Solos Breast Endoscopy System and the continued interest in and growth of our base products. We are in the process of significantly increasing our customer base and look forward to further increasing our sales in 2008," stated Dee Fletcher, Vice President of Sales for Solos Endoscopy, Inc.
About Solos Endoscopy, Inc.:
Solos Endoscopy, Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office. Additional information is available on the Company's website at: www.solosendoscopy.com.
Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
Source: Solos Endoscopy
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.